Dr. Mary Eapen, MD

Dr. Eapen practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Eapen's NPI, 1306897210, was assigned on May 15, 2006. Dr. Eapen holds Wisconsin license 42290.

Dr. Eapen's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Eapen's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Eapen is also affiliated with Children's Wisconsin. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eapen practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Dr. Eapen's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Eapen is licensed in Wisconsin.

CMS data shows 73 Medicare services from Dr. Eapen across 1 procedure code in 2024, for 27 Medicare patients. Medicare paid $4,376 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Eapen in 2024. The largest group is 75 to 84, with 12 patients. 75% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 3.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eapen's median patient age at 65, with 53% women.

In 2024, Dr. Eapen wrote 57 Medicare Part D claims for 15 patients. 95% of them were for generic drugs. CMS names the drug for 36 of them, across 3 drugs with 11 or more claims each, at $532 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Eapen for performance year 2024, reported as part of a group. Dr. Eapen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 143 papers to Dr. Eapen, published from 2006 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Transplantation Conditioning. Dr. Eapen has published most often in Biol Blood Marrow Transplant. Dr. Eapen's most frequent co-authors are Mary M. Horowitz, MD, Michael Allen Pulsipher, MD and Joseph Harry Antin, MD.

CMS Open Payments shows 7 general payments to Dr. Eapen from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 77% of the total. National Marrow Donor Program paid the most, $1,416.